chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative: Patient received his COVID-19 vaccine (Moderna) dose #1 on 2/23/21. During the observation period, the patient reported feeling dizzy after receiving the vaccine. Patient was responsive and talking. Patient color WNL,  breathing at a normal rate, and sitting in a chair. Initial vital signs as follows-> BP: 162/100, 02: 990 0, P: 95. Patient reported that he is a diabetic, he took his oral medications this morning and ate oatmeal. Patient denied that this could be an episode low blood sugar. Patient's notable non-hospital medications are: losartan he was previously prescribed), ASA 81mg, glyburide 10mg BID, pioglitazone 45mg daily, and metformin 1000mg BID. [Med info obtained from non-hospital record review (JLV system).] Patient report a history of anxiety and hypertension. Patient  was evaluated by the vaccine clinic physicians. Patient's blood glucose checked at approximately 11:10am and was 192. Patient was monitored and vitals reassessed after another 5-10 minutes. Vitals were as follows: BP: 147/82, HR: 89, 02: 980%. Patient sent home once feeling better.
heart muscle inflammation; swelling in throat/sore throat; gaining weight faster; not metabolizing food; fever 99.4 progressed to 100.6F; sore throughout the body; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (heart muscle inflammation) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 038C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COVID-19 (Positive For Covid-19). Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (LOESTRIN) for an unknown indication.   On 09-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (heart muscle inflammation) (seriousness criterion medically significant), PHARYNGEAL SWELLING (swelling in throat/sore throat), WEIGHT INCREASED (gaining weight faster), MALABSORPTION (not metabolizing food), PYREXIA (fever 99.4 progressed to 100.6F) and MYALGIA (sore throughout the body). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MYOCARDITIS (heart muscle inflammation), WEIGHT INCREASED (gaining weight faster) and MALABSORPTION (not metabolizing food) outcome was unknown and PHARYNGEAL SWELLING (swelling in throat/sore throat), PYREXIA (fever 99.4 progressed to 100.6F) and MYALGIA (sore throughout the body) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.4 °f (High) mild fever of 99.4  °F progressed to 100.6.         Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the medical history of COVID-19could be a contributory factor.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: TCR document was received on 27-JUL-2021 and contained significant information. Events of heart muscle inflammation, no food metabolizing, and gaining weight faster were updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the medical history of COVID-19could be a contributory factor.
After eating at two different restaurants that use MSG , one a chinese restaurant and one a barbeque restaurant. the patient had an entire day where (the following day after dinner) I felt "drunk", ill, off balance, some what dizzy for an entire day, flu like symptoms, etc. The patient stated "I would like to see MSG banned". Also she would like for doctors to be informed that on vaccinations when traveling especially Hepatitis B vaccine, doses should be monitored. Stating " I had a strong reaction. Later my doctor said I should have been given a half dose".
Information has been received from a pharmacist referring to a patient of unknown age and gender. Information regarding medical history, concurrent condition and concomitant medication was not provided. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (dose, lot# and expiration date unknown, once) intramuscularly by another pharmacist. No adverse effect were reported. Additional information has been requested.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose02/12/21 2nd dose03/05/21 Diagnosed covid positive:09/18/21 Symptom onset:09/15/21 Exposure: Symptoms:fever, fatigue,muscleaches,abdpain,chills
suspected vaccination failure; shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: The patient had reported for him/herself.  The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. The patient further stated that the patient's immune system was wonky. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
loss of appetite, temperature, bad headaches, fatigue, injection site sore for 8 days(pink, little hot), just generally not up to par at all for 3 days
Injection was given very high on my L arm. Vaccinator said she had difficulty injecting vaccine-taking about 15 seconds to complete injection. Injection was painful. Within 1 hour I could not raise my arm more than 30 degrees without severe pain. Diminished ROM and pain at night is ongoing. Within 4 hours, I had a low grade fever with chills, headache and myalgia that persisted for 12 hours then respoved.  I am awaiting an appointment with my primary care physician and will know then if more treatment will be recommended. Incident Report filed at the hospital.
This case was reported by a nurse to a sales representative and described the occurrence of injection site stinging in an adult subject of unspecified gender who was vaccinated with hepatitis B vaccine recombinant for prophylaxis.  The nurse reported to the sales representative that, "85 percent of the subjects that received Engerix-B from the pre-filled syringe have complained of stinging at the injection site," however, subject identifiers were not provided. On an unspecified date on or after "mid" September 2005 and on or before 10/12/2005, the subject received unspecified dose of Engerix-B.  At an unspecified time following the administration of Engerix-B, on an unspecified date on or after "mid" September 2005 and on or before 10/12/2005, less than one month after vaccination with Engerix-B, the subject experienced injection site stinging.  The outcome of the injection site stinging was not reported.  The nurse reported to the sales representative that she, "is hearing more complaints of injection site stinging with Engerix-B prefilled syringes.  The office switched over to the Engerix-B prefilled syringe in mid September 2005."  The nurse also reported that the office, "also has hepatitis A inactivated and hepatitis B recombinant vaccine prefilled syringes but are not hearing any complaints of stinging with those."
pt stopped breathing, lips were blue, twitching of body, eyes in a stare; was taken by ambulance to hosp, was adm for observation; hosp gave APAP for fever which was t100.5 when arrived @ hosp; pt did not remain in hosp-no insurance;
Received the vaccine ZOSTAVAX and in 10 days broke out with shingles.
PT HAD STEROID OINT PRESCRIBED. WAS GOING TO SEE THE DR TODAY. BUT NO CALL BACK. I LEFT A MESSAGE FOR PT TO CALL BACK
About 10 patients including this one appeared with a welt-like formation ranging in size from 2-3  inches on the vaccinated arm about 2 days following administration. All reactions had completely resolved by 11/12. All of these vaccine reactions originated from the same lot and expiration date of FLUARIX.
This spontaneous report was received from a Licensed practical nurse refers to a multiple unspecified patients of an unknown age and gender. The patients relevant medical history, concurrent condition and concomitant medication were not reported. On an unknown date, the multiple unspecified patients were vaccinated with improperly stored (Oka/Merck) VARIVAX, Lot# M004328 (expiry date: 26-JAN-2018, Lot# L048462 (expiry date: 02-DEC-2017 and lot# M023384 (expiry date: 11-MAY-2018) (dose not reported). No adverse effects reported. No Product Quality Complaint (PQC) was involved. This is one of two reports received from the same reporter. Additional information has been requested.
Sore arm; Red circle; Body ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red circle), MYALGIA (Body ache) and PYREXIA (Fever) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 0251202A) for COVID-19 vaccination.     The patient's past medical history included Hives. Previously administered products included for Product used for unknown indication: Influenza (Route: Intramuscular and Body site/side: Left bicep). Past adverse reactions to the above products included No adverse event with Influenza. Concurrent medical conditions included Blood pressure high (High blood pressure (controlled for 12 years)) since 2009, Klippel-Feil syndrome, Chronic back pain, Drug allergy (Reaction: hives), Drug allergy (Reaction: hives) since 2004, Asthma, Depression since 2003, Anxiety since 2003 and Pain. Concomitant products included BUSPIRONE for Anxiety, PAROXETINE for Depression, LISINOPRIL for Hypertension, AMITRIPTYLINE and MELOXICAM for Pain, GALCANEZUMAB (EMGALITY [GALCANEZUMAB]) for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red circle), MYALGIA (Body ache) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Red circle), MYALGIA (Body ache) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: normal (normal) Normal. On an unknown date, Laboratory test: normal (normal) Normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   After First dose patient had no side effects. No treatment information was reported. It was unknown if patient had a medical history of hay fever.   This case was linked to MOD-2021-396172 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Nov-2021: Follow up received includes reporter information added, patient demographics added, medical history added, Laboratory data added, new concomitant medication lisinopril added and previous concomitant medications dosage regimen information updated and added,
Information has been received from a public health care nurse concerning a patient who on 10AUG1999 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient developed chickenpox breakthrough. It was noted that this case was part of 4 cases of chickenpox breakthrough on of which was "mild" and the other three "regular chickenpox". Unspecified medical attention was sought. There was no product quality complaint involved. The reporter also mentioned three other patients who developed chickenpox breakthrough experienced similar reactions (WAES0403USA01867, WAES0403USA01868, WAES0403USA01869.  Subsequently, the reporter mentioned two additional patients who developed breakthrough varicella. Additional information is not expected.
Patient reported puffy face, scabbing across face and body, itching, eyes swollen closed. Some of these symptoms lasted weeks.
headache, body aches, chills, and 102 fever. Swollen lymph node under ear
Arm wont stop hurting; Pain moving from shoulder to neck and pain interfering with sleep; pain interfering with his sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm wont stop hurting), PAIN (Pain moving from shoulder to neck and pain interfering with sleep) and INSOMNIA (pain interfering with his sleep) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a210) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol total abnormal NOS.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm wont stop hurting), PAIN (Pain moving from shoulder to neck and pain interfering with sleep) and INSOMNIA (pain interfering with his sleep). At the time of the report, PAIN IN EXTREMITY (Arm wont stop hurting), PAIN (Pain moving from shoulder to neck and pain interfering with sleep) and INSOMNIA (pain interfering with his sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also include : Blood pressure medication and Cholesterol medication
Patient's arm became swollen and red from injection site to elbow. He states he went to the hospital and it was infected and he was admitted.
Patient felt like his "there was swelling under his tongue" about 6 minutes after receiving2nd dose of  Pfizer Cov 19 vaccine in the pharmacy.  Referred patient to Clinic. Patient was not in distress, his tongue and airway appeared normal and his vital signs were normal with exception of mildly elevated blood pressure.  Patient states his feeling of "swelling under his tongue" had resolved within 20 minutes and during his assessment in Clinic. Patient was discharge home at 12:30 PM.
Localized rash x3 days to trunk of body.  Fine maculopapular rash with slight erythematous base confined only to trunk. Non febrile. Treated with anti-histamine medications.
After Dose #2 Muscle swelled and red mark just below vaccination site same day.  Next day fatigue, chills, sweats, diarrhea, low grade fever, burping Next day pain above stomach below breast bone, nauseau, vomiting, indigestion, burping. Next day arm still swollen, red spot much larger, itchy, hot.
loss of strength; radical change./ began in my legs and then moved thru my body/ the vaccine entered into my nervous system; lost my gate and stumble quite often; I've fallen twice last week/stumble quite often; This case was reported by a consumer and described the occurrence of strength loss of in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st February 2021, the patient received the 2nd dose of Shingrix. On 9th February 2021, 8 days after receiving Shingrix, the patient experienced strength loss of, radiating pain, walking difficulty and fall. On an unknown date, the outcome of the strength loss of, radiating pain, walking difficulty and fall were unknown.   It was unknown if the reporter considered the strength loss of, radiating pain, walking difficulty and fall to be related to Shingrix.  Additional details were provided are as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix and his/her body went into a radical change, began in legs and then moved to body and he/she could still felt where the shot was given, lost his/her gate and stumble quite often and had fallen twice last week and believed that vaccine entered into nervous system and the shot was given on the left side and felt often loss of strength mostly on that side. The reporter asked question that would this dissipate or would this be permanent-way of life for him.
flue like symptoms; Vaccine exposure during pregnancy; headache; nausea; chills; little fever ( do not know the temperature); extreme body aches like someone had beat her; pain at the arm of the injection after the 2nd dose; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flue like symptoms), EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) in a 36-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Induced abortion (blood problem, the baby did not come out, had to have surgery) in 2018 and Spontaneous abortion in 2012. Concurrent medical conditions included Hemochromatosis and Blood disorder NOS.   On 02-Feb-2021 at 5:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021 at 5:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 28-Jan-2021 and the estimated date of delivery was 03-Oct-2021. On 09-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flue like symptoms), EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills), PYREXIA (little fever ( do not know the temperature)), MYALGIA (extreme body aches like someone had beat her) and INJECTION SITE PAIN (pain at the arm of the injection after the 2nd dose). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth week of the pregnancy.  At the time of the report, INFLUENZA LIKE ILLNESS (flue like symptoms), EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills), PYREXIA (little fever ( do not know the temperature)), MYALGIA (extreme body aches like someone had beat her) and INJECTION SITE PAIN (pain at the arm of the injection after the 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Pregnancy test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included an unspecified allergy medicine.  No treatment medication was reported.   This case was linked to MOD-2021-210217 (Patient Link).
Patient with syncope after vaccine. Recovered well. Provided rest and water. Vitals stable. Sent home.
Throat felt like it was closing up, face/upper body extremely flushed, itchiness on left forearm with small hives, uncontrollable shaking, difficulty breathing, numbness & tingling in face, left arm, and both legs.
Local reaction, mild erythema (L) lat deltoid region approx 4 cm x 3 cm. S/S mild.
major back pain/back pain; hip tightness; Hip pain; This spontaneous case was reported by a patient and describes the occurrence of BACK PAIN (major back pain/back pain), MUSCLE TIGHTNESS (hip tightness) and ARTHRALGIA (Hip pain) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced BACK PAIN (major back pain/back pain) (seriousness criterion hospitalization), MUSCLE TIGHTNESS (hip tightness) (seriousness criterion hospitalization) and ARTHRALGIA (Hip pain) (seriousness criterion hospitalization). At the time of the report, BACK PAIN (major back pain/back pain), MUSCLE TIGHTNESS (hip tightness) and ARTHRALGIA (Hip pain) had not resolved.            No concomitant drug was reported. On 12-Nov-2021, patient received first booster dose. It was reported that patient received first and second dose as a full dose. The patient was concerned that they might have a side effect of the vaccine. The adverse events caused patient to seek medical care. No treatment drug was reported. Company Comment This spontaneous case concerns a 57-years-old, with no medical history reported who experienced the unexpected seriousness criteria hospitalization events of back pain, muscle tightness and arthralgia unknown days after  3rd. dose of  mRNA-1273 vaccine.  At the time of the report, the event had not resolved.   The benefit-risk relationship of mRNA-1273 is not affected by this report. Events seriousness was assessed based on medical judgement.; Sender's Comments: Company Comment This spontaneous case concerns a 57-years-old, with no medical history reported who experienced the unexpected seriousness criteria hospitalization events of back pain, muscle tightness and arthralgia unknown days after  3rd. dose of  mRNA-1273 vaccine.  At the time of the report, the event had not resolved.   The benefit-risk relationship of mRNA-1273 is not affected by this report. Events seriousness was assessed based on medical judgement.
Patient said her arm was red, swollen and warm from the injection site all the way down to her elbow. It was still like this 3 days after the vaccination, she was instructed to contact her PCP and he gave her Benadryl for several days and said it was just a localized reaction.
Flu shot given in right arm. Experienced right upper arm pain, migrated to right shoulder, decreased mobility right shoulder. Diagnosed with right frozen shoulder, am undergoing physical therapy.
Migraine pet-symptoms began around 1:30Pm, progressing into a full blown migraine 7:30-8:30 PM. I was afraid to take my sumatriptan medication at onset of migraine due to lack of knowledge of impact of efficacy of vaccine. I tried treating with Advil alone. Intense pain persisted through night and next day last night. I finally took a sumatriptan at 3:30 AM this morning. As of 7:28 AM today, I am pain free
Incorrect timing of administration: Pt was given dose 2 moderna 0.5ml  at day 21 instead of day 28.
severe headache, muscle aches, anorexia, nausea and vomiting on an empty stomach that resolved by 5 PM on the next day Aug 28 2019
the night of vaccine, i became fatigued and sore. the next day i had a fever of between 100 and 103 F. My muscles and all my joints were incredibly painful. I bruised almost every time something touched me. My scalp was sore and my mouth was sore. When i took/take a deep breath, i feel short of breath. when i am up walking around, i can feel my heart beating funny.